| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036955 |
| Receipt No. | R000042103 |
| Scientific Title | Effect of supplement containing pig placenta extracts on skin quality in healthy adult women: a randomized, double-blind, placebo-controlled study |
| Date of disclosure of the study information | 2020/03/25 |
| Last modified on | 2019/06/04 (Ver. 1) |
| Basic information | ||
| Public title | Effect of supplement containing pig placenta extracts on skin quality in healthy adult women: a randomized, double-blind, placebo-controlled study | |
| Acronym | Pig placenta supplement clinical trial; a randomized, double-blind, placebo-controlled study | |
| Scientific Title | Effect of supplement containing pig placenta extracts on skin quality in healthy adult women: a randomized, double-blind, placebo-controlled study | |
| Scientific Title:Acronym | Pig placenta supplement clinical trial; a randomized, double-blind, placebo-controlled study | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult women | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy of supplement containing Pig placenta extracts for skin quality in healthy adult women |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin quality measurement |
| Key secondary outcomes | OSA sleep inventory MA version
Simplified Menopausal Index (SMI) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | To intake supplements containing pig placenta2 tablets/day for 4 weeks. | |
| Interventions/Control_2 | To intake placebo 2 tablets/day for 4 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | (1) Persons who is generally judged as healthy
(2) Persons who can give voluntary written consent to participate in the present trial |
|||
| Key exclusion criteria | (1) Persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study
(2) Persons who have changed their habitats to take supplements or to use cosmetics within past 4 weeks. (3) Persons who work in night shift or in day and night shift (4) Persons who have been treated their illness or prevention in a clinic at their informed consent (5) Persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6) Persons with the medical histories of alcoholism or drug dependence (7) Persons who might be developed allergic reaction to foods. (8) Persons who are pregnant,breast-feeding, or hope to be pregnant during the study period (9) Persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10) Persons who will not be judged suitable to the participants by the investigator. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Faculty of Agriculture, Kyushu University | ||||||
| Division name | Laboratory of Systematic Forest and Forest Products Science | ||||||
| Zip code | 812-8582 | ||||||
| Address | 744 Motooka, Nishi-ku, Fukuoka, Fukuoka, JAPAN | ||||||
| TEL | 092-802-4673 | ||||||
| shimizu@agr.kyushu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Faculty of Agriculture, Kyushu University | ||||||
| Division name | Laboratory of Systematic Forest and Forest Products Science | ||||||
| Zip code | 812-8582 | ||||||
| Address | 744 Motooka, Nishi-ku, Fukuoka, Fukuoka, JAPAN | ||||||
| TEL | 092-802-4673 | ||||||
| Homepage URL | |||||||
| shimizu@agr.kyushu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Faculty of Agriculture, Kyushu University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kashu Industries Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Faculty of Humanity-Oriented Science and Engineering, Kindai University |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kindai University Faculty of Humanity-Oriented Science and Engineering Ethics Committee |
| Address | 11-6 Kayanomori, Iizuka city, Fukuoka 820-8555, JAPAN |
| Tel | 0948-22-5655 |
| ohnuki@fuk.kindai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042103 |